Hot Topics

(Image: Getty/BrianAJackson)

AAPS 2017

Quality-by-design: How to mitigate risk in drug development

By Melissa Fassbender

As the industry continues to externalize components of the supply chain, global regulatory authorities are requiring a “quality-by-design” (QbD) approach to help mitigate risk across the drug development process.